guest ::
| Home > Publications database > General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. > print |
| Home > Publications database > General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. > print |
| 001 | 128879 | ||
| 005 | 20240228143354.0 | ||
| 024 | 7 | _ | |a 10.1016/j.jneuroim.2016.05.014 |2 doi |
| 024 | 7 | _ | |a pmid:27397084 |2 pmid |
| 024 | 7 | _ | |a 0165-5728 |2 ISSN |
| 024 | 7 | _ | |a 1872-8421 |2 ISSN |
| 024 | 7 | _ | |a altmetric:8124641 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-04892 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Keil, Melanie |0 P:(DE-He78)1f4e474ebc02bd0cf008f2b9098525d2 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2016 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1524467266_26994 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Relapsing-remitting multiple sclerosis (MS)(2) is characterized by phases of acute neuroinflammation followed by spontaneous remission. Termination of inflammation is accompanied by an influx of regulatory T cells (Tregs).(3) The molecular mechanisms responsible for directing Tregs into the inflamed CNS tissue, however, are incompletely understood. In an MS mouse model we show that the stress kinase general control non-derepressible 2 (GCN2),(4) expressed in T cells, contributes to the resolution of autoimmune neuroinflammation. Failure to recover from acute inflammation was associated with reduced frequencies of CNS-infiltrating Tregs. GCN2 deficient Tregs displayed impaired migration to a CCL2 gradient. These data suggest an important contribution of the T cell stress response to the resolution of autoimmune neuroinflammation. |
| 536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Annexin A5 |2 NLM Chemicals |
| 650 | _ | 7 | |a Cytokines |2 NLM Chemicals |
| 650 | _ | 7 | |a Myelin-Oligodendrocyte Glycoprotein |2 NLM Chemicals |
| 650 | _ | 7 | |a Peptide Fragments |2 NLM Chemicals |
| 650 | _ | 7 | |a myelin oligodendrocyte glycoprotein (35-55) |2 NLM Chemicals |
| 650 | _ | 7 | |a Eif2ak4 protein, mouse |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Protein-Serine-Threonine Kinases |0 EC 2.7.11.1 |2 NLM Chemicals |
| 700 | 1 | _ | |a Sonner, Jana |0 P:(DE-He78)1f1efec9a95d1778031cb6f0b19ba58b |b 1 |u dkfz |
| 700 | 1 | _ | |a Lanz, Tobias |0 P:(DE-He78)22a10e47ef85d2b98a12b21a7f332e56 |b 2 |u dkfz |
| 700 | 1 | _ | |a Oezen, Iris |0 P:(DE-He78)19ad2213f94e3900fa9a1b02f36b965a |b 3 |u dkfz |
| 700 | 1 | _ | |a Bunse, Theresa |0 P:(DE-He78)e681100c540b628a2bdbd48772b4fb50 |b 4 |u dkfz |
| 700 | 1 | _ | |a Bittner, Stefan |b 5 |
| 700 | 1 | _ | |a Meyer, Hannah V |b 6 |
| 700 | 1 | _ | |a Meuth, Sven G |b 7 |
| 700 | 1 | _ | |a Wick, Wolfgang |0 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |b 8 |u dkfz |
| 700 | 1 | _ | |a Platten, Michael |0 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5 |b 9 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1016/j.jneuroim.2016.05.014 |g Vol. 297, p. 117 - 126 |0 PERI:(DE-600)1500497-1 |p 117 - 126 |t Journal of neuroimmunology |v 297 |y 2016 |x 0165-5728 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:128879 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)1f4e474ebc02bd0cf008f2b9098525d2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)1f1efec9a95d1778031cb6f0b19ba58b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)22a10e47ef85d2b98a12b21a7f332e56 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)19ad2213f94e3900fa9a1b02f36b965a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)e681100c540b628a2bdbd48772b4fb50 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |2 G:(DE-HGF)POF3-300 |v Translational cancer research |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROIMMUNOL : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)G808-20160331 |k G808 |l IMT IM Platform |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l Pädiatrische Neuroonkologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)G370-20160331 |k G370 |l KKE Neuroonkologie |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)G160-20160331 |k G160 |l Neuroimmunologie und Hirntumorimmunologie |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 4 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)G808-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G370-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G160-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|